We are live on ! Find out more
CNSY

Cerenome
CNSY

9 hedge funds and large institutions have $182K invested in Cerenome in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

0.74% less ownership

Funds ownership: 3.1% → 2.36% (-0.74%)

18% less funds holding

Funds holding: 11 → 9 (-2)

27% less capital invested

Capital invested by funds: $247K → $182K (-$65.6K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
9
Holders Change
-2
Holders Change %
-18.18%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$6.29K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$5.27K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$30.2K
2
GSC
Ground Swell Capital
South Carolina
-$25.6K
3
UBS Group
UBS Group
Switzerland
-$15.6K
4
Citadel Advisors
Citadel Advisors
Florida
-$11.9K

CNSY Hedge Fund Activity: Q1 2024 in Review

9 of the 6,959 institutional investors tracked by Wall St. Rank reported a position in Cerenome (CNSY) for Q1 2024, worth a combined $182K — down 27% from $247K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of CNSY and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $6.29K. The largest seller was Renaissance Technologies, cutting an estimated $30.2K.

  • 9 institutional investors held Cerenome (CNSY) as of Q1 2024, down from 11 in Q4 2023.
  • Funds reported $182K of Cerenome stock for Q1 2024, down 27% quarter-over-quarter.
  • 0 funds opened new Cerenome positions in Q1 2024 and 2 closed out, a net change of -2 holders.
  • The largest Cerenome buyer in Q1 2024 was Tower Research Capital (TRC), an estimated $6.29K added.
  • The largest Cerenome seller in Q1 2024 was Renaissance Technologies, an estimated $30.2K sold.

Based on aggregated 13F filings for Q1 2024.